Serdar Arıcı

8PUBLICATIONS
18CO-AUTHORS
Neural engineeringCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 13, 2026
Body Mass Index Does Not Predict High Miller-Payne Response to Neoadjuvant Chemotherapy in Stage II-III Breast Cancer: A Single-Center Retrospective Cohort Study of 647 Patients.

|Feb 17, 2025
Perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in gastric cancer: Pathological regression grade and its relationship to clinical outcome.

Muhammed M Atci, Saban Secmeler, Abdullah Sakin

|Apr 19, 2021
Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study.

Muhammed Mustafa Atcı, Çağlayan Geredeli, Seval Ay

|Oct 01, 2020
The conversion of RAS status in metastatic colorectal cancer patients after first-line biological agent treatment.

Serdar Arici, Jamshid Hamdard, Abdullah Sakin

|May 20, 2020
Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer.

Deniz Tataroglu Ozyukseler, Mustafa Basak, Seval Ay

|Jan 21, 2020
The predictive role of metabolic tumor volume on no response to neoadjuvant chemotherapy in patients with breast cancer.

Serdar Arici, Sevda S Karyagar, Savas Karyagar

Pageof 2

Frequent Collaborators

5 joint publications

Abdullah Sakin

4 joint publications

Caglayan Geredeli

4 joint publications

Nurgul Yasar

4 joint publications

Sener Cihan